E

Enlivex Therapeutics Ltd
D

ENLV

0.91100
USD
-0.06
(-6.24%)
مغلق
حجم التداول
6,359
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
215,262,771
أصول ذات صلة الأخبار المقالات

العنوان: Enlivex Therapeutics Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.